Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cellebrite

Founders Yossi Carmil

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 2
Rounds per year 0.09
Lead investments 2
Key employees Soon

Areas of investment

  • Security
  • Telecommunications
  • Mobile Devices
  • Cyber Security
  • Enterprise Software
Summary

Cellebrite appeared to be the Corporate Investor, which was created in 1999. The venture was found in Asia in Israel. The main department of described Corporate Investor is located in the Petah Tiqva.

The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2013.

The standard case for the fund is to invest in rounds with 1 partaker. Despite the Cellebrite, startups are often financed by PLUS Ventures.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. Among the most popular portfolio startups of the fund, we may highlight CommuniTake Technologies. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Software, Telecommunications.

The fund was created by Yossi Carmil.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cellebrite:
Typical Co-investors
Cellebrite is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cellebrite:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Blue Dynamic -
GLOBAL AGRINNO Hungary, Vas, Vasvár
H&M CO:LAB Stockholm, Stockholm County, Sweden
Hawkshead Capital -
Hezhi Capital China, Guangdong, Shenzhen
Petrichor Healthcare Capital Management New York, New York, United States
Shanda Holdings -
Tennessee Community Ventures Nashville, Tennessee, United States
Value Invest Korea (VIK) Seoul, Seoul-t'ukpyolsi, South Korea

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

CommuniTake Technologies

Cyber Security
Enterprise Software
Mobile Devices
Security
Software
Telecommunications
$3M21 Apr 2013 North District

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cellebrite?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 1M
Rounds per year 0.09
Peak activity year 2013
Lead investments 2

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

CommuniTake Technologies

Cyber Security
Enterprise Software
Mobile Devices
Security
Software
Telecommunications
$3M21 Apr 2013 North District
Crunchbase icon

Content report

The following text will be sent to our editors: